Prakt. lékáren. 2010; 6(3): 125-128

Pharmacological treatment of migraine and tension headache

MUDr.Ingrid Niedermayerová
Neurologická ambulance Quattromedica Brno
Neurologická klinika FN Brno

Currently, the so-called stratified treatment is used in migraine therapy. In mild attacks, analgesics and antirheumatics are given orally

while in moderate attacks these medications are administered parenterally and coupled with antiemetics. Specific antimigraine drugs

(triptans) are indicated in moderate and severe attacks. When the attacks increase in frequency or acute treatment fails to show sufficient

effect, prophylaxis by means of beta blockers, antiepileptics or antidepressants is used. Tension headache is treated with simple

analgesics, in the case of increased frequency antidepressants can be given as prophylaxis and supplemented by nonpharmacological



methods:

Keywords: headache, migraine, acute treatment, prophylaxis, analgesics, triptans, tension headache

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Niedermayerová I. Pharmacological treatment of migraine and tension headache. Praktické lékárenství. 2010;6(3):125-128.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Stratified Care vs Step Care Strategies for migraine. The Disability in Strategies of care (DISC) Study: Randomised Trial. JAMA. 2000; 284; 2599-2605. Go to original source... Go to PubMed...
    2. Relja G, Granato A, Antonello RD, Zorzon M. Headache Induced by Chronic Substance Use: Analysis of Medication Overused and Minimum Dose Required to Induce Headache. Headache 2004; 44: 148-153. Go to original source... Go to PubMed...
    3. The International Classification of Headache Disorders. 2nd Edition, Cephalgia 2003; 24(Suppl 1/24): 1-160.
    4. Waberžinek G. Bolesti hlavy. Praha: Triton, 2000: 66-116.
    5. Doležal T, Slíva J. Nimesulidum. Remedia 2004; 14: 2-10.
    6. Rainsford KD. Current status of the therapeutic uses and actions of the preferential cyklo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology. 2006; 14: 120-137. Go to original source... Go to PubMed...
    7. Slíva J, Doležal T, Kršiak M. Přehled analgetik. Praha: Tigis, 2004.
    8. Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. European Journal of Neurology 2006; 13: 560-572. Go to original source... Go to PubMed...
    9. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001; 358: 1668-1675. Go to original source... Go to PubMed...
    10. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headaches in a general population. J Clin Epidemiol. 1991; 44: 1147-1157. Go to original source... Go to PubMed...
    11. Diener H. Established treatment strategies for varying clinical situations. The 13th Congress of the IHS 2007, Stockholm, Sweden.
    12. Mastík J. Specifická léčba migrény. Interní Med. 2007; 4: 188-191.
    13. Ho TW, Ferrari M, Dodick DW, et al. Acute antimigraine efficacy and tolerability of novel oral CGRP antagonist MK0974, a phase III clinical trial versus placebo and zolmitriptan. European Headache and Migraine Trust International Congress 2008, London, UK.
    14. Peatfield P. Dodick DW. Headaches. Oxford: Fine Print, 2002: 176-201.
    15. Niedermayerová I, Mastík J. Lisinopril je účinný v profylaxi migrény. Practicus. 2007; 5-6: 200-203.
    16. Opavský J, Doležil D, Mastík J, Marková J, Grünermelová M, Niedermayerová I, Rejda J, Dočekal P, Opavská H. Comparison between migraine treatment by headache specialists and primary care physicians in the Czech republic. Cephalalgia. 2007; 27: 652-653.
    17. Dočekal P, Keller O, Marková J, Opavský J. Bolesti hlavy. In: Rokyta R, Kršiak M, Kozák J (Eds). Bolest. Praha: Tigis, 2006: 461-476.
    18. Češková E. Duálně působící antidepresiva. Remedia 2006; 16: 594-597.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.